These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 28288570

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
    Al Therwani S, Malmberg MES, Rosenbaek JB, Bech JN, Pedersen EB.
    BMC Nephrol; 2017 Aug 15; 18(1):268. PubMed ID: 28810844
    [Abstract] [Full Text] [Related]

  • 4. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.
    Mose FH, Jensen JM, Therwani S, Mortensen J, Hansen AB, Bech JN, Pedersen EB.
    Br J Clin Pharmacol; 2015 Sep 15; 80(3):425-35. PubMed ID: 25778445
    [Abstract] [Full Text] [Related]

  • 5. Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney.
    Jensen JM, Mose FH, Bech JN, Nielsen S, Pedersen EB.
    BMC Nephrol; 2013 Sep 26; 14():202. PubMed ID: 24067081
    [Abstract] [Full Text] [Related]

  • 6. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
    Mose FH, Larsen T, Jensen JM, Hansen AB, Bech JN, Pedersen EB.
    Scand J Clin Lab Invest; 2014 Jan 26; 74(1):8-19. PubMed ID: 24256611
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease.
    Mose FH, Larsen T, Jensen JM, Hansen AB, Bech JN, Pedersen EB.
    Br J Clin Pharmacol; 2014 Oct 26; 78(4):789-99. PubMed ID: 24697877
    [Abstract] [Full Text] [Related]

  • 9. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK, Larsen T, Vase H, Lauridsen TG, Jensen JM, Pedersen EB.
    Clin Exp Hypertens; 2013 Oct 26; 35(5):313-24. PubMed ID: 22966789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of sodium nitrite infusion on renal function, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamide in healthy subjects: a randomized, double-blinded, placebo-controlled, crossover study.
    Rosenbaek JB, Pedersen EB, Bech JN.
    BMC Nephrol; 2018 Sep 21; 19(1):244. PubMed ID: 30241504
    [Abstract] [Full Text] [Related]

  • 13. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC, Smith WB, Boerrigter G, Ouyang J, Zimmer CA, Orlandi C, Burnett JC.
    Am J Physiol Renal Physiol; 2006 Feb 21; 290(2):F273-8. PubMed ID: 16189291
    [Abstract] [Full Text] [Related]

  • 14. Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney.
    Lauridsen TG, Vase H, Bech JN, Nielsen S, Pedersen EB.
    Eur J Endocrinol; 2010 May 21; 162(5):961-9. PubMed ID: 20203161
    [Abstract] [Full Text] [Related]

  • 15. Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans.
    Starklint J, Bech JN, Pedersen EB.
    Scand J Clin Lab Invest; 2005 May 21; 65(3):249-61. PubMed ID: 16095054
    [Abstract] [Full Text] [Related]

  • 16. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
    Larsen T, Mose FH, Bech JN, Pedersen EB.
    Clin Exp Hypertens; 2012 May 21; 34(8):567-74. PubMed ID: 22559218
    [Abstract] [Full Text] [Related]

  • 17. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.
    Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB.
    Am J Physiol; 1998 May 21; 274(5):F914-23. PubMed ID: 9612329
    [Abstract] [Full Text] [Related]

  • 18. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls.
    Jensen JM, Mose FH, Kulik AE, Bech JN, Fenton RA, Pedersen EB.
    BMC Nephrol; 2014 Jun 26; 15():101. PubMed ID: 24970686
    [Abstract] [Full Text] [Related]

  • 19. Effects of dihydralazine on renal water and aquaporin-2 excretion in humans.
    Vase H, Lauridsen TG, Bech JN, Pedersen EB.
    Scand J Clin Lab Invest; 2009 Jun 26; 69(1):45-51. PubMed ID: 18728933
    [Abstract] [Full Text] [Related]

  • 20. Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels.
    Lauridsen TG, Vase H, Starklint J, Graffe CC, Bech JN, Nielsen S, Pedersen EB.
    BMC Nephrol; 2010 Oct 28; 11():28. PubMed ID: 21029429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.